HUTCHMED

HUTCHMED (HCM) CEO Dr. Weiguo Su is taking a leave of absence for health reasons. CFO Johnny Cheng has been appointed Acting CEO, retaining his CFO responsibilities. The Board assures that ongoing research, development, and commercial activities will remain on track. Dr. Su expressed confidence in the team’s ability to execute the company’s strategy. Cheng acknowledged Dr. Su’s 20 years of leadership and contributions to HUTCHMED.